Skip to content

Author

T. Aspelund

We have 4 of 534 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Adverse childhood experiences and labour market inactivity among young women: a population-based study

Young people not in employment, education, or training (NEET) are a major concern presenting extensive societal and personal costs. Adverse childhood experiences (ACEs) can have longstanding harmful effects on health, education and employment participation. This study examined if ACEs are associated with NEET sta...

H. S. Eyjólfsdóttir, Marín Dögg Bjarnadóttir, H. Daníelsdóttir et al. · 0 citations
Open access Sep 2026

Screening for obstructive sleep apnoea in the general population in Iceland and uptake of positive airway pressure treatment: a prospective cohort study

Among those with moderate-to-severe OSA identified through population screening, most accepted evaluation and PAP treatment, with approximately half becoming long-term users, suggesting that population-based detection of OSA followed by routine clinical management is feasible.

E. H. Thorarinsdottir, B. Benediktsdóttir, T. Aspelund et al. · 0 citations
Open access Jul 2026

Psychiatric genetic liability is associated with the severity of COVID-19 and other acute respiratory infections: an observational study across five Northern European countries

The results underscore the role of psychiatric genetic liability, beyond diagnosed psychiatric disorders, in contributing to both COVID-19 and other respiratory infection severity, and provide insights that may improve future risk stratification and public health strategies targeting respiratory viruses.

K. Kõiv, R. Askeland, L. N. Christoffersen et al. · 0 citations
Open access Jul 2026

Cardiometabolic Risk and Awareness of Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer: A Population-Based Study.

It is suggested that survivors treated with anthracyclines require systematic surveillance and targeted interventions to address modifiable cardiovascular risk factors and increasing awareness of prior cardiotoxic cancer treatment among survivors and health care providers may facilitate cardiovascular risk reduction.

Vigdís H Viggósdóttir, H. Helgason, Helga Jónsdóttir et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.